An open-label study of 80 patients with irritable bowel syndrome (IBS) found that those who knew they were receiving a placebo still experienced improvements, including reduced symptom severity, compared to those who did not receive any additional treatment. Read more at here.
Placebos without deception effective for IBS
Most Recent Content
For Nurse Practitioners
Will Omicron Be More Contagious Than Delta?
If the first thing you heard about the omicron variant over the holiday weekend was that it is bad news, the second thing was...
